P H Scanlon

836 total citations
23 papers, 626 citations indexed

About

P H Scanlon is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P H Scanlon has authored 23 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Ophthalmology, 17 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P H Scanlon's work include Retinal Diseases and Treatments (18 papers), Retinal Imaging and Analysis (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). P H Scanlon is often cited by papers focused on Retinal Diseases and Treatments (18 papers), Retinal Imaging and Analysis (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). P H Scanlon collaborates with scholars based in United Kingdom, Canada and China. P H Scanlon's co-authors include C. Foy, S J Aldington, Irene Stratton, Max Bachmann, James N. Kirkpatrick, George Thomas, Raman Malhotra, Fred K. Chen, Colin Jones and Jonathan R. Abbas and has published in prestigious journals such as Diabetologia, British Journal of Ophthalmology and Diabetic Medicine.

In The Last Decade

P H Scanlon

23 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P H Scanlon United Kingdom 12 530 487 90 78 31 23 626
Shirley Rosen Israel 12 224 0.4× 206 0.4× 27 0.3× 45 0.6× 10 0.3× 19 412
W Piehlmeier Germany 9 113 0.2× 112 0.2× 93 1.0× 44 0.6× 38 1.2× 21 324
Ankur Gupta United States 4 136 0.3× 257 0.5× 12 0.1× 19 0.2× 9 0.3× 6 347
Woon Cho Kim United States 8 88 0.2× 124 0.3× 34 0.4× 56 0.7× 1 0.0× 21 285
Shehla Baqai Pakistan 5 27 0.1× 28 0.1× 241 2.7× 114 1.5× 11 0.4× 32 365
Raviv Allon Israel 10 66 0.1× 53 0.1× 7 0.1× 70 0.9× 4 0.1× 33 261
Aukje van Gestel Netherlands 8 209 0.4× 143 0.3× 1 0.0× 162 2.1× 13 0.4× 11 382
Jamal Moosavi Iran 6 63 0.1× 71 0.1× 5 0.1× 41 0.5× 16 0.5× 38 204
C. Mitchell Gilbert United States 7 414 0.8× 169 0.3× 7 0.1× 16 0.2× 7 556
Kaveri Mandal United Kingdom 9 180 0.3× 165 0.3× 3 0.0× 9 0.1× 12 267

Countries citing papers authored by P H Scanlon

Since Specialization
Citations

This map shows the geographic impact of P H Scanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P H Scanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P H Scanlon more than expected).

Fields of papers citing papers by P H Scanlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P H Scanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P H Scanlon. The network helps show where P H Scanlon may publish in the future.

Co-authorship network of co-authors of P H Scanlon

This figure shows the co-authorship network connecting the top 25 collaborators of P H Scanlon. A scholar is included among the top collaborators of P H Scanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P H Scanlon. P H Scanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stratton, Irene, et al.. (2016). FACTORS DETERMINING PATIENT UPTAKE OF DIABETIC RETINOPATHY SCREENING IN OXFORDSHIRE. European Journal of Ophthalmology. 26. 2 indexed citations
2.
Scanlon, P H, et al.. (2016). Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age. Diabetic Medicine. 33(12). 1655–1658. 20 indexed citations
3.
Aldington, S J, et al.. (2015). BARRIERS AND MOTIVATORS FOR ATTENDANCE AT DIABETIC RETINOPATHY SCREENING. European Journal of Ophthalmology. 25. 2 indexed citations
4.
Oke, Jason, Irene Stratton, S J Aldington, Richard Stevens, & P H Scanlon. (2015). The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme. Diabetic Medicine. 33(7). 896–903. 11 indexed citations
5.
Scanlon, P H, Irene Stratton, Graham Leese, et al.. (2015). Research: Complications Screening attendance, age group and diabetic retinopathy level at first screen. 1 indexed citations
6.
Scanlon, P H, Irene Stratton, Graham Leese, et al.. (2015). Screening attendance, age group and diabetic retinopathy level at first screen. Diabetic Medicine. 33(7). 904–911. 42 indexed citations
7.
Stratton, Irene, et al.. (2014). Validation of model to estimate risk of progression of diabetic retinopathy using screening and clinical data in 3 cohorts. Diabetologia. 57. 1 indexed citations
8.
Stratton, Irene, S J Aldington, Andrew Farmer, & P H Scanlon. (2014). Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?. Oxford University Research Archive (ORA) (University of Oxford). 4 indexed citations
9.
Scanlon, P H, et al.. (2013). A grounded theory exploration of young adults' non-attendance at diabetic retinopathy screening appointments. Diabetic Medicine. 30. 176–176. 4 indexed citations
10.
Scanlon, P H, et al.. (2013). Updating Diabetic Retinopathy Screening Lists using Automatic Extraction from GP Patient Records. Journal of Medical Screening. 20(3). 111–117. 2 indexed citations
11.
Ross, Adam H., Paul H. J. Donachie, Ahmed B. Sallam, et al.. (2012). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?. Eye. 27(1). 56–64. 33 indexed citations
12.
13.
Scanlon, P H, et al.. (2009). RETINAL VESSEL OXIMETRY USING HYPERSPECTRAL IMAGING IN DIABETIC RETINOPATHY. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
14.
Scanlon, P H, et al.. (2008). Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. Journal of Medical Screening. 15(3). 118–121. 54 indexed citations
15.
Scanlon, P H, C. Foy, & Fred K. Chen. (2008). Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening. British Journal of Ophthalmology. 92(6). 775–778. 33 indexed citations
16.
Scanlon, P H. (2008). Article Commentary: The English national screening programme for sight-threatening diabetic retinopathy. Journal of Medical Screening. 15(1). 1–4. 93 indexed citations
17.
18.
Scanlon, P H. (2003). Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. British Journal of Ophthalmology. 87(10). 1258–1263. 126 indexed citations
19.
Scanlon, P H, Raman Malhotra, George Thomas, et al.. (2003). The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabetic Medicine. 20(6). 467–474. 111 indexed citations
20.
Scanlon, P H. (2000). Commentary: Screening for Diabetic Retinopathy by Digital Imaging Photography and Technician Ophthalmoscopy. Diabetes Technology & Therapeutics. 2(2). 283–287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shirley Rosen Breakdown of academic impact, for papers by W Piehlmeier Breakdown of academic impact, for papers by Ankur Gupta Breakdown of academic impact, for papers by Woon Cho Kim Breakdown of academic impact, for papers by Shehla Baqai Breakdown of academic impact, for papers by Raviv Allon Breakdown of academic impact, for papers by Aukje van Gestel Breakdown of academic impact, for papers by Jamal Moosavi Breakdown of academic impact, for papers by C. Mitchell Gilbert Breakdown of academic impact, for papers by Kaveri Mandal
Rankless by CCL
2026